Big Pharma Gave Money To Patient Advocacy Groups Opposing Medicare Changes
A KHN database shows that $58 million flowed from drugmakers to patient groups running national ads.
The independent source for health policy research, polling, and news.
821 - 840 of 1,300 Results
A KHN database shows that $58 million flowed from drugmakers to patient groups running national ads.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
KHN correspondent Emmarie Huetteman appeared on the C-SPAN program 鈥淲ashington Journal,鈥 where she fielded viewers鈥 calls about high drug prices and industry criticism.
In a new poll, consumers give thumbs up to ads that display drug prices and the removal of barriers to generics, among other cost-cutting measures.
Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Jennifer Haberkorn of the Los Angeles Times join KHN鈥檚 Julie Rovner to discuss the new 鈥淢edicare-for-all鈥 bill introduced by House Democrats, the grilling of pharmaceutical company CEOs by a Senate committee and new Trump administration rules that take aim at Planned Parenthood. Plus, Rovner interviews KHN鈥檚 Julie Appleby about the latest 鈥淏ill of the Month鈥 installment.
The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
Tuesday鈥檚 Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.
The state鈥檚 governor said the plan has the full support of the White House. But the Trump administration was noncommittal about whether allowing states to buy and import cheaper drugs from up north could be the answer to the nation鈥檚 drug-pricing problem.
Most hearings before the U.S. House and Senate are routine affairs. But a few tense moments featuring everyone from Hillary Clinton to tobacco CEOs drew the attention of millions of Americans.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Tuesday鈥檚 Senate hearing with pharma CEOs will tackle the same issues as the famous Kefauver hearings in 1960.
Confrontational hearings 60 years ago sparked remarkably similar quotes about drug prices and health care policy.
In an emerging new tactic against the rising toll of opioid deaths, California, Ohio, Virginia and Arizona are among the states requiring physicians to offer patients naloxone when they give them prescriptions for the powerful painkillers. The Food and Drug Administration is weighing a national recommendation to do so.
Medicare and many private insurers view prescribing drugs to improve sexual function as a lifestyle issue that鈥檚 not medically necessary to pay for.
The 鈥淢edicare鈥揻or-all鈥 debate is already in full swing, but what does that phrase even mean? Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN鈥檚 Julie Rovner for a beginner鈥檚 guide to the next big health policy debate. For 鈥渆xtra credit,鈥 the panelists provide their favorite health policy stories of the week, and as a special Valentine鈥檚 Day bonus, their favorite #HealthPolicyValentines.
Unwilling to wait for federal action, California Gov. Gavin Newsom says he has a plan that could extract discounts from drugmakers and save the state money 鈥 one he hopes other states can join.
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?
Sen. Mike Enzi said he knew of a foundation that would import insulin for patients, but it doesn鈥檛 appear to exist.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Just as each person鈥檚 journey into addiction is unique, different approaches work for people trying to find their way out. For me, detoxing was nightmarish. And a long-held dream come true.
漏 2026 KFF